Aprea Therapeutics, Inc.
APRE- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001781983
No open-market purchases or sales by Aprea Therapeutics, Inc. insiders were filed in the last 90 days; 27 institutions reported holding it in 13F filings for Q2 2026, worth $1.90M in total; no superinvestor holds it.
Q2 2021 vs. Q1 2021
How the institutions holding Aprea Therapeutics, Inc. changed between Q1 2021 and Q2 2021.
All holders in Q2 2021All holders in Q1 2021
| Measure | Q1 2021 | Q2 2021 | Change |
|---|---|---|---|
| Holders | 67 | 50 | −17 |
| Shares | 8.93M | 6.54M | −2.39M (−26.8%) |
| Value | $45.4M | $31.9M | −$13.5M (−29.7%) |
New holders (9)
Institutions that held Aprea Therapeutics, Inc. at the end of Q2 2021 but not at the end of Q1 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| PDT Partners, LLC | 124,234 | $606.0K | 0.04% |
| Susquehanna International Group, LLP | 73,061 | $357.0K | 0.00% |
| Millennium Management LLC | 33,203 | $162.0K | 0.00% |
| Citadel Advisors LLC | 28,619 | $140.0K | 0.00% |
| Acadian Asset Management LLC | 18,557 | $91.0K | 0.00% |
| Ergoteles LLC | 18,570 | $91.0K | 0.00% |
| Great Lakes Advisors, LLC | 17,895 | $87.0K | 0.00% |
| Quantamental Technologies LLC | 13,752 | $67.0K | 0.06% |
| Two Sigma Securities, LLC | 11,962 | $58.0K | 0.01% |
Sold out (26)
Institutions that held Aprea Therapeutics, Inc. at the end of Q1 2021 and filed for Q2 2021 without it.